Rapid screen, complement control cells, panocell 20, and immucor reagents

Ended Awarded

Contract number
HT001424F0012
Awardee
Awarding agency
Obligated
$18,288

Award facts

Contract value 100% obligated
$18,287.55 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Fort Belvoir, VA 22060, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

Immucor Inc. was awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency on October 18, 2023. The contract has a potential value of $18,287.55 and requires delivery of Rapid Screen, Complement Control Cells, Panocell 20, and Immucor reagents by October 17, 2024 at Fort Belvoir, Virginia. No set-aside designation was used for this award to support the Defense Health Agency's medical products procurement programs. Immucor Inc. will serve as the prime contractor to provide the requested blood banking supplies.

Quick answers

Who was awarded contract HT001424F0012?

HT001424F0012 was awarded to Immucor Inc. by Defense Health Agency (Department of Defense) on October 18, 2023.

How much is contract HT001424F0012 worth?

The government has obligated $18,288 on HT001424F0012.

Is contract HT001424F0012 an order under another contract?

Yes. HT001424F0012 is a BPA call under HT001420A0010, a blanket purchase agreement.

Was contract HT001424F0012 competed?

The extent of competition for HT001424F0012 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login